Latest News About Antylia Scientific

Here are the latest publicly reported developments on Antylia Scientific:

• Acquisition and ownership: In 2025, Antylia Scientific was acquired by Brookfield Asset Management and CDPQ for approximately $1.34 billion, with GTCR previously having owned the company. This aligns with a broader trend of consolidation in life sciences tooling and diagnostic assets.[5]
• Corporate history: The company originated as Cole-Parmer Instrument Company and rebranded to Antylia Scientific in 2021, expanding its two main divisions into Bioprocessing and Life Sciences. This branding reflects a strategic emphasis on end-to-end lab instrumentation and bioprocessing solutions.[2][4]
• Market positioning: Antylia positions itself as a global supplier of peristaltic and single-use bioprocessing equipment, along with a broad portfolio of life-sciences and diagnostic products for pharma, healthcare, and environmental markets. Public materials emphasize growth through both organic R&D and acquisitions to extend product lines.[3][4][2]

If you want, I can pull more details on recent press releases, key product lines, or the financial terms of the Brookfield/CDPQ deal and summarize them with citations.